Alex Kramm
Stock Analyst at UBS
(4.74)
# 671
Out of 4,693 analysts
653
Total ratings
63%
Success rate
11.2%
Average return
Main Sectors:
Stocks Rated by Alex Kramm
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BR Broadridge Financial Solutions | Maintained: Hold | $165 → $180 | $182.38 | -1.30% | 10 | Aug 17, 2026 | |
| MRX Marex Group | Maintained: Buy | $60 → $90 | $72.48 | +24.17% | 7 | Aug 13, 2026 | |
| CWK Cushman & Wakefield | Rated: Hold | $17 → $15 | $13.49 | +11.19% | 10 | Aug 10, 2026 | |
| ICE Intercontinental Exchange | Rated: Buy | $190 → $195 | $160.70 | +21.34% | 56 | Jul 31, 2026 | |
| MKTX MarketAxess Holdings | Downgraded: Hold | $200 → $167 | $162.63 | +2.69% | 19 | Jul 31, 2026 | |
| CBRE CBRE Group | Maintained: Buy | $185 → $190 | $145.81 | +30.31% | 25 | Jul 30, 2026 | |
| VRSK Verisk Analytics | Maintained: Hold | $220 → $235 | $193.78 | +21.27% | 39 | Jul 30, 2026 | |
| NDAQ Nasdaq | Maintained: Buy | $120 | $98.61 | +21.69% | 46 | Jul 24, 2026 | |
| CME CME Group | Maintained: Hold | $260 | $285.50 | -8.93% | 58 | Jul 23, 2026 | |
| MCO Moody's | Maintained: Hold | $490 → $505 | $504.64 | +0.07% | 56 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $115 → $125 | $110.98 | +12.63% | 3 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $550 → $525 | $435.84 | +20.46% | 51 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 → $260 | $218.94 | +18.75% | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $380 → $340 | $313.55 | +8.44% | 38 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $720 | $570.64 | +26.17% | 42 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 → $150 | $107.70 | +39.28% | 29 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $305 → $335 | $300.20 | +11.59% | 40 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $425 → $445 | $365.87 | +21.63% | 26 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 | $65.64 | -31.44% | 32 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 | $31.98 | +56.35% | 5 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $20 | $18.00 | n/a | 8 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $73 | $82.97 | n/a | 13 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $19.80 | n/a | 1 | Jun 28, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $44 → $50 | $109.82 | n/a | 12 | Mar 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $40 | $370.14 | n/a | 7 | Feb 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $0.0001 | n/a | 3 | Jul 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $210 | $1,155.61 | n/a | 1 | Oct 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $29 | $32.78 | n/a | 1 | Sep 13, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $117 → $120 | $34.15 | n/a | 2 | Sep 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $32 | - | n/a | 3 | Sep 6, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $48.39 | n/a | 1 | Jun 12, 2012 |
Broadridge Financial Solutions
Aug 17, 2026
Maintained: Hold
Price Target: $165 → $180
Current: $182.38
Upside: -1.30%
Marex Group
Aug 13, 2026
Maintained: Buy
Price Target: $60 → $90
Current: $72.48
Upside: +24.17%
Cushman & Wakefield
Aug 10, 2026
Rated: Hold
Price Target: $17 → $15
Current: $13.49
Upside: +11.19%
Intercontinental Exchange
Jul 31, 2026
Rated: Buy
Price Target: $190 → $195
Current: $160.70
Upside: +21.34%
MarketAxess Holdings
Jul 31, 2026
Downgraded: Hold
Price Target: $200 → $167
Current: $162.63
Upside: +2.69%
CBRE Group
Jul 30, 2026
Maintained: Buy
Price Target: $185 → $190
Current: $145.81
Upside: +30.31%
Verisk Analytics
Jul 30, 2026
Maintained: Hold
Price Target: $220 → $235
Current: $193.78
Upside: +21.27%
Nasdaq
Jul 24, 2026
Maintained: Buy
Price Target: $120
Current: $98.61
Upside: +21.69%
CME Group
Jul 23, 2026
Maintained: Hold
Price Target: $260
Current: $285.50
Upside: -8.93%
Moody's
Jul 23, 2026
Maintained: Hold
Price Target: $490 → $505
Current: $504.64
Upside: +0.07%
Jul 23, 2026
Maintained: Buy
Price Target: $115 → $125
Current: $110.98
Upside: +12.63%
Jul 7, 2026
Rated: Buy
Price Target: $550 → $525
Current: $435.84
Upside: +20.46%
Jul 7, 2026
Rated: Buy
Price Target: $280 → $260
Current: $218.94
Upside: +18.75%
Jul 2, 2026
Rated: Buy
Price Target: $380 → $340
Current: $313.55
Upside: +8.44%
Jun 26, 2026
Maintained: Buy
Price Target: $720
Current: $570.64
Upside: +26.17%
May 11, 2026
Rated: Buy
Price Target: $145 → $150
Current: $107.70
Upside: +39.28%
May 4, 2026
Maintained: Hold
Price Target: $305 → $335
Current: $300.20
Upside: +11.59%
Apr 22, 2026
Rated: Buy
Price Target: $425 → $445
Current: $365.87
Upside: +21.63%
Jan 15, 2026
Maintained: Hold
Price Target: $45
Current: $65.64
Upside: -31.44%
Jan 15, 2026
Maintained: Hold
Price Target: $50
Current: $31.98
Upside: +56.35%
Aug 14, 2025
Maintained: Hold
Price Target: $2 → $20
Current: $18.00
Upside: n/a
Feb 8, 2023
Maintained: Buy
Price Target: $70 → $73
Current: $82.97
Upside: n/a
Jun 28, 2017
Reiterated: Sell
Price Target: n/a
Current: $19.80
Upside: n/a
Mar 13, 2017
Rated: Buy
Price Target: $44 → $50
Current: $109.82
Upside: n/a
Feb 10, 2017
Reiterated: Hold
Price Target: $35 → $40
Current: $370.14
Upside: n/a
Jul 16, 2013
Reiterated: Buy
Price Target: $17 → $18
Current: $0.0001
Upside: n/a
Oct 18, 2012
Rated: Buy
Price Target: $210
Current: $1,155.61
Upside: n/a
Sep 13, 2012
Maintained: Buy
Price Target: $29
Current: $32.78
Upside: n/a
Sep 12, 2012
Maintained: Hold
Price Target: $117 → $120
Current: $34.15
Upside: n/a
Sep 6, 2012
Maintained: Buy
Price Target: $35 → $32
Current: -
Upside: n/a
Jun 12, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $48.39
Upside: n/a